Administration of the broad‐spectrum HDAC inhibitor suberoylanilide hydroxamic acid (Vorinostat) to R6/2 transgenic mice, which express exon 1 of the human HD gene and exhibit human HD‐like phenotypes, increased protein acetylation in the brain and rescued motor damage [163]. Here, HDAC9 is linked to Huntington disease.